S744 Risankizumab Induction Therapy Provides Early Symptom Improvements in Abdominal Pain and Stool Frequency in Patients With Moderate to Severe Crohn’s Disease: Results From Two Phase 3 Induction Studies
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI